Filing Details

Accession Number:
0001140361-16-068345
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-02 18:21:33
Reporting Period:
2016-05-31
Filing Date:
2016-06-02
Accepted Time:
2016-06-02 18:21:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238403 K Daniel Spiegelman C/O Biomarin Pharmaceutical Inc.,
770 Lindaro St.
San Rafael CA 94901
Evp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-31 16,896 $39.06 71,235 No 4 M Direct
Common Stock Disposition 2016-05-31 16,896 $90.00 54,339 No 4 S Direct
Common Stock Disposition 2016-05-31 3,945 $89.35 50,394 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to buy) Common Stock Acquisiton 2016-05-31 16,896 $0.00 16,896 $39.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,604 2012-11-29 2022-05-28 No 4 M Direct
Footnotes
  1. Trade made pursuant to a 10b5-1 plan executed on May 9, 2016.
  2. All shares were sold at the same price.
  3. Reflects the number of stock options outstanding after the transaction from this specific stock option grant.